Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management

被引:492
作者
Hirsch, MS
Conway, B
D'Aquila, RT
Johnson, VA
Brun-Vézinet, F
Clotet, B
Demeter, LM
Hammer, SM
Jacobsen, DM
Kuritzkes, DR
Loveday, C
Mellors, JW
Vella, S
Richman, DD
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Massachusetts Gen Hosp, Infectious Dis Unit, Boston, MA 02114 USA
[3] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
[4] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
[5] Vet Affairs Med Ctr, Birmingham, AL USA
[6] Hop Bichat Claude Bernard, F-75877 Paris 18, France
[7] Hosp Badalona Germans Trias & Pujol, Fdn Irsa Caixa, Barcelona, Spain
[8] Hosp Badalona Germans Trias & Pujol, HIV Unit, Barcelona, Spain
[9] Univ Rochester, Rochester, NY 14627 USA
[10] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
[11] Royal Free Hosp, Sch Med, London, England
[12] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA
[13] Ist Super Sanita, I-00161 Rome, Italy
[14] Univ Calif San Diego, San Diego, CA 92103 USA
[15] Vet Affairs Med Ctr, San Diego, CA 92161 USA
[16] Int AIDS Soc USA, San Francisco, CA 94129 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 279卷 / 24期
关键词
D O I
10.1001/jama.279.24.1984
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives.-To review current knowledge of the biology and clinical implications of human immunodeficiency virus (HIV) resistance to antiretroviral drugs, describe assays for measuring resistance, and assess their use in clinical practice. Participants.-The international AIDS Society-USA assembled a panel of 13 physicians with expertise in basic science, clinical research, and patient care relevant to HIV resistance to antiretroviral drugs. Evidence.-We reviewed available data from published reports and presented at national and international research conferences. Basic science research, clinical trial results, and expert opinions were used to form the basis of this report, Data on methods for and characteristics of specific genotypic and phenotypic assays were obtained from manufacturers and service providers. Consensus Process.-The panel met regularly between October 1997 and April 1998, Panel subgroups developed and discussed different sections of the report before discussing them with the entire panel. Conclusions and suggested approaches to the use of resistance testing were determined by group consensus. Conclusions.-Plasma HIV RNA level and CD4(+) cell count are the primary values that should be used to guide the initiation of antiretroviral therapy and subsequent changes in therapy. Possible causes of treatment failure other than development of drug resistance that should be considered are adherence, drug potency, and pharmacokinetic issues, Genotypic and phenotypic testing for HIV resistance to antiretroviral drugs may prove useful for individual patient management. Assays under development need validation, standardization, and a clearer definition of their clinical roles, Possible current roles of resistance testing for choosing an initial regimen or changing antiretroviral therapy, as well as possible implications of the presence or absence of phenotypic resistance and genotypic changes, are discussed.
引用
收藏
页码:1984 / 1991
页数:8
相关论文
共 90 条
  • [71] Schinazi R. F., 1997, International Antiviral News, V5, P129
  • [72] Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials - Compensatory modulations of binding and activity
    Schock, HB
    Garsky, VM
    Kuo, LC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) : 31957 - 31963
  • [73] RAPID CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD AND APPEARANCE OF DRUG-RESISTANT VIRUS POPULATIONS IN PERSONS TREATED WITH LAMIVUDINE (3TC)
    SCHUURMAN, R
    NIJHUIS, M
    VANLEEUWEN, R
    SCHIPPER, P
    DEJONG, D
    COLLIS, P
    DANNER, SA
    MULDER, J
    LOVEDAY, C
    CHRISTOPHERSON, C
    KWOK, S
    SNINSKY, J
    BOUCHER, CAB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (06): : 1411 - 1419
  • [74] COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE SELECTS FOR DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS WITH UNIQUE PATTERNS OF POL GENE-MUTATIONS
    SHAFER, RW
    KOZAL, MJ
    WINTERS, MA
    IVERSEN, AKN
    KATZENSTEIN, DA
    RAGNI, MV
    MEYER, WA
    GUPTA, P
    RASHEED, S
    COOMBS, R
    KATZMAN, M
    FISCUS, S
    MERIGAN, TC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04) : 722 - 729
  • [75] CHANGES IN DRUG SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING THERAPY WITH AZIDOTHYMIDINE, DIDEOXYCYTIDINE, AND DIDEOXYINOSINE - AN INVITRO COMPARATIVE-STUDY
    SHIRASAKA, T
    YARCHOAN, R
    OBRIEN, MC
    HUSSON, RN
    ANDERSON, BD
    KOJIMA, E
    SHIMADA, T
    BRODER, S
    MITSUYA, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) : 562 - 566
  • [76] Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
    Singh, N
    Squier, C
    Sivek, C
    Wagener, M
    Nguyen, MH
    Yu, VL
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1996, 8 (03): : 261 - 269
  • [77] SOMMADOSSI JP, 1998, 5 C RETR OPP INF FEB
  • [78] RESISTANCE TO DDI AND SENSITIVITY TO AZT INDUCED BY A MUTATION IN HIV-1 REVERSE-TRANSCRIPTASE
    STCLAIR, MH
    MARTIN, JL
    TUDORWILLIAMS, G
    BACH, MC
    VAVRO, CL
    KING, DM
    KELLAM, P
    KEMP, SD
    LARDER, BA
    [J]. SCIENCE, 1991, 253 (5027) : 1557 - 1559
  • [79] Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene
    Stuyver, L
    Wyseur, A
    Rombout, A
    Louwagie, J
    Scarcez, T
    Verhofstede, C
    Rimland, D
    Schinazi, RF
    Rossau, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) : 284 - 291
  • [80] Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet
    Tachedjian, G
    Mellors, J
    Bazmi, H
    Birch, C
    Mills, J
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (10) : 7171 - 7181